ATH 12.5% 0.5¢ alterity therapeutics limited

Election of Mr. Lawrence Gozlan to Serve as a DirectorMr....

  1. 183 Posts.
    Election of Mr. Lawrence Gozlan to Serve as a Director

    Mr. Gozlan, a leading biotechnology investor and advisor, is the Chief Investment Officer and Founder
    of Scientia Capital, a specialised global investment fund focused exclusively in life sciences. The
    Company was founded to provide high level expertise and to manage investments for high net worth
    individuals, family offices and institutional investors wanting exposure to the biotechnology industry.
    Prior to this, Mr. Gozlan was responsible for the largest biotechnology investment portfolio in Australia
    as the institutional biotechnology analyst at QIC (?the Queensland Investment Corporation?), an
    investment fund with over AU$60 billion under management. He previously worked as the senior
    biotechnology analyst in the equities team at Foster Stockbroking, and gained senior corporate finance
    experience advising life sciences companies at Deloitte.
    Mr. Gozlan is an investment advisor to several companies in the biotechnology industry, presented at
    numerous international healthcare conferences, and has been featured in various published media as
    an expert on investing in life sciences. He holds a Bachelor of Science with Honours in microbiology
    and immunology from the University of Melbourne specializing in neurodegenerative diseases.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(12.5%)
Mkt cap ! $23.60M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $5 1.097K

Buyers (Bids)

No. Vol. Price($)
4 20342 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 100000 1
View Market Depth
Last trade - 12.51pm 03/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.